← FDA Drug Approvals (Drugs@FDA)

INBRIJA

NDA · New Drug Application · Sponsor: MERZ · Approved 2018-12-21

Drug application

FDA Application #

NDA209184

Application type

New Drug Application

Brand name

INBRIJA

Generic name

LEVODOPA

Active ingredients

LEVODOPA

Dosage form

POWDER

Route

INHALATION

Marketing status

Prescription

Sponsor

MERZ

Manufacturer

Merz Pharmaceuticals, LLC

First approval

2018-12-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown